Literature DB >> 18754031

Systematic genomic screen for tyrosine kinase mutations in CLL.

J R Brown, R L Levine, C Thompson, G Basile, D G Gilliland, A S Freedman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18754031      PMCID： PMC2704549          DOI： 10.1038/leu.2008.222

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  8 in total

1.  ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia.

Authors:  Laura Z Rassenti; Lang Huynh; Tracy L Toy; Liguang Chen; Michael J Keating; John G Gribben; Donna S Neuberg; Ian W Flinn; Kanti R Rai; John C Byrd; Neil E Kay; Andrew Greaves; Arthur Weiss; Thomas J Kipps
Journal:  N Engl J Med       Date:  2004-08-26       Impact factor: 91.245

2.  Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.

Authors:  Ross L Levine; Martha Wadleigh; Jan Cools; Benjamin L Ebert; Gerlinde Wernig; Brian J P Huntly; Titus J Boggon; Iwona Wlodarska; Jennifer J Clark; Sandra Moore; Jennifer Adelsperger; Sumin Koo; Jeffrey C Lee; Stacey Gabriel; Thomas Mercher; Alan D'Andrea; Stefan Fröhling; Konstanze Döhner; Peter Marynen; Peter Vandenberghe; Ruben A Mesa; Ayalew Tefferi; James D Griffin; Michael J Eck; William R Sellers; Matthew Meyerson; Todd R Golub; Stephanie J Lee; D Gary Gilliland
Journal:  Cancer Cell       Date:  2005-04       Impact factor: 31.743

3.  Genomic aberrations and survival in chronic lymphocytic leukemia.

Authors:  H Döhner; S Stilgenbauer; A Benner; E Leupolt; A Kröber; L Bullinger; K Döhner; M Bentz; P Lichter
Journal:  N Engl J Med       Date:  2000-12-28       Impact factor: 91.245

4.  EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Authors:  J Guillermo Paez; Pasi A Jänne; Jeffrey C Lee; Sean Tracy; Heidi Greulich; Stacey Gabriel; Paula Herman; Frederic J Kaye; Neal Lindeman; Titus J Boggon; Katsuhiko Naoki; Hidefumi Sasaki; Yoshitaka Fujii; Michael J Eck; William R Sellers; Bruce E Johnson; Matthew Meyerson
Journal:  Science       Date:  2004-04-29       Impact factor: 47.728

5.  Somatic mutations and germline sequence variants in the expressed tyrosine kinase genes of patients with de novo acute myeloid leukemia.

Authors:  Michael H Tomasson; Zhifu Xiang; Richard Walgren; Yu Zhao; Yumi Kasai; Tracie Miner; Rhonda E Ries; Olga Lubman; Daved H Fremont; Michael D McLellan; Jacqueline E Payton; Peter Westervelt; John F DiPersio; Daniel C Link; Matthew J Walter; Timothy A Graubert; Mark Watson; Jack Baty; Sharon Heath; William D Shannon; Rakesh Nagarajan; Clara D Bloomfield; Elaine R Mardis; Richard K Wilson; Timothy J Ley
Journal:  Blood       Date:  2008-02-12       Impact factor: 22.113

6.  Prevalence of familial malignancy in a prospectively screened cohort of patients with lymphoproliferative disorders.

Authors:  Jennifer R Brown; Donna Neuberg; Kimberly Phillips; Hazel Reynolds; Jason Silverstein; Jennifer C Clark; Megan Ash; Christina Thompson; David C Fisher; Eric Jacobsen; Ann S LaCasce; Arnold S Freedman
Journal:  Br J Haematol       Date:  2008-08-20       Impact factor: 6.998

7.  High-throughput sequence analysis of the tyrosine kinome in acute myeloid leukemia.

Authors:  Marc M Loriaux; Ross L Levine; Jeffrey W Tyner; Stefan Fröhling; Claudia Scholl; Eric P Stoffregen; Gerlinde Wernig; Heidi Erickson; Christopher A Eide; Roland Berger; Olivier A Bernard; James D Griffin; Richard M Stone; Benjamin Lee; Matthew Meyerson; Michael C Heinrich; Michael W Deininger; D Gary Gilliland; Brian J Druker
Journal:  Blood       Date:  2008-02-05       Impact factor: 22.113

8.  Patterns of somatic mutation in human cancer genomes.

Authors:  Christopher Greenman; Philip Stephens; Raffaella Smith; Gillian L Dalgliesh; Christopher Hunter; Graham Bignell; Helen Davies; Jon Teague; Adam Butler; Claire Stevens; Sarah Edkins; Sarah O'Meara; Imre Vastrik; Esther E Schmidt; Tim Avis; Syd Barthorpe; Gurpreet Bhamra; Gemma Buck; Bhudipa Choudhury; Jody Clements; Jennifer Cole; Ed Dicks; Simon Forbes; Kris Gray; Kelly Halliday; Rachel Harrison; Katy Hills; Jon Hinton; Andy Jenkinson; David Jones; Andy Menzies; Tatiana Mironenko; Janet Perry; Keiran Raine; Dave Richardson; Rebecca Shepherd; Alexandra Small; Calli Tofts; Jennifer Varian; Tony Webb; Sofie West; Sara Widaa; Andy Yates; Daniel P Cahill; David N Louis; Peter Goldstraw; Andrew G Nicholson; Francis Brasseur; Leendert Looijenga; Barbara L Weber; Yoke-Eng Chiew; Anna DeFazio; Mel F Greaves; Anthony R Green; Peter Campbell; Ewan Birney; Douglas F Easton; Georgia Chenevix-Trench; Min-Han Tan; Sok Kean Khoo; Bin Tean Teh; Siu Tsan Yuen; Suet Yi Leung; Richard Wooster; P Andrew Futreal; Michael R Stratton
Journal:  Nature       Date:  2007-03-08       Impact factor: 49.962
  8 in total
  12 in total

1.  MET receptor sequence variants R970C and T992I lack transforming capacity.

Authors:  Jeffrey W Tyner; Luke B Fletcher; Ellen Q Wang; Wayne F Yang; Michael L Rutenberg-Schoenberg; Carol Beadling; Motomi Mori; Michael C Heinrich; Michael W Deininger; Brian J Druker; Marc M Loriaux
Journal:  Cancer Res       Date:  2010-08-01       Impact factor: 12.701

2.  Sequence analysis of 515 kinase genes in chronic lymphocytic leukemia.

Authors:  X Zhang; M Reis; R Khoriaty; Y Li; P Ouillette; J Samayoa; H Carter; R Karchin; M Li; L A Diaz; V E Velculescu; N Papadopoulos; K W Kinzler; B Vogelstein; S N Malek
Journal:  Leukemia       Date:  2011-06-24       Impact factor: 11.528

3.  Characteristics of chronic lymphocytic leukemia with somatically acquired mutations in NOTCH1 exon 34.

Authors:  K Shedden; Y Li; P Ouillette; S N Malek
Journal:  Leukemia       Date:  2011-12-20       Impact factor: 11.528

Review 4.  The biology and clinical significance of acquired genomic copy number aberrations and recurrent gene mutations in chronic lymphocytic leukemia.

Authors:  S N Malek
Journal:  Oncogene       Date:  2012-09-24       Impact factor: 9.867

Review 5.  Genomic approaches to chronic lymphocytic leukemia.

Authors:  Ma Reina Improgo; Jennifer R Brown
Journal:  Hematol Oncol Clin North Am       Date:  2013-04       Impact factor: 3.722

Review 6.  Our changing view of the genomic landscape of cancer.

Authors:  Daphne W Bell
Journal:  J Pathol       Date:  2010-01       Impact factor: 7.996

7.  Quantitative DNA methylation analysis identifies a single CpG dinucleotide important for ZAP-70 expression and predictive of prognosis in chronic lymphocytic leukemia.

Authors:  Rainer Claus; David M Lucas; Stephan Stilgenbauer; Amy S Ruppert; Lianbo Yu; Manuela Zucknick; Daniel Mertens; Andreas Bühler; Christopher C Oakes; Richard A Larson; Neil E Kay; Diane F Jelinek; Thomas J Kipps; Laura Z Rassenti; John G Gribben; Hartmut Döhner; Nyla A Heerema; Guido Marcucci; Christoph Plass; John C Byrd
Journal:  J Clin Oncol       Date:  2012-05-07       Impact factor: 44.544

8.  Comprehensive molecular oncogenomic profiling and miRNA analysis of prostate cancer.

Authors:  Seema Sethi; Dejuan Kong; Sue Land; Gregory Dyson; Wael A Sakr; Fazlul H Sarkar
Journal:  Am J Transl Res       Date:  2013-03-28       Impact factor: 4.060

Review 9.  From cancer genomes to cancer models: bridging the gaps.

Authors:  Anaïs Baudot; Francisco X Real; José M G Izarzugaza; Alfonso Valencia
Journal:  EMBO Rep       Date:  2009-03-20       Impact factor: 8.807

10.  The phosphoinositide 3-kinase signaling pathway in normal and malignant B cells: activation mechanisms, regulation and impact on cellular functions.

Authors:  Samantha D Pauls; Sandrine T Lafarge; Ivan Landego; Tingting Zhang; Aaron J Marshall
Journal:  Front Immunol       Date:  2012-08-09       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.